Petauri Health
in the news

Rapidly growing Petauri Health adds exceptional talent to its executive roster. NEW YORK September 21, 2023 — Petauri Health, a New York-based, purpose-built pharmaceutical services platform, announced today that it has added to its executive ranks with 3 experienced leaders who straddle information technology, operations, and finance. Jeff Petet, CHCIO, has been named SVP, Information […]

Rapidly growing Petauri Health adds top talent to its executive team NEW YORK July 12, 2023 — Petauri Health, a New York–based, purpose-built pharmaceutical services platform, announced today that it has named Mridul Malhotra to the dual role of Chief Strategic Officer (CSO) and Global Head: Evidence, Value, and Access (EVA). In this newly created […]

Petauri Health’s initial acquisition marks a key milestone in its mission to offer integrated commercialization solutions. NEW YORK June 13, 2023 — Petauri Health, a New York–based, purpose-built pharmaceutical services platform, announced today that it has acquired The Kinetix Group, also known as TKG. Founded by John Strapp and Sarah McNulty, The Kinetix Group is […]

PM360 asked experts in developing market access strategies how the Inflation Reduction Act will impact drug pricing negotiation and other access-related issues as well as what other big trends in the space will force the industry to rethink its strategies.  See how our own Dan Renick responded:

Oak Hill Capital and life sciences industry leader Dan Renick team up to create new organization offering integrated commercialization solutions. NEW YORK February 1st, 2023 – Oak Hill Capital, a New York-based middle-market private equity firm, announced today that it has partnered with Dan Renick to launch Petauri Health (“Petauri” or “the Company”), a purpose-built […]